Gritstone bio
Gritstone Presents Positive Results from Two Phase 1 CORAL Studies
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001193125-22-268408
- Signs a material agreement (1.01)
- Sells unregistered shares (3.02)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2836) and public float not reported.
- Adaptimmune Therapeutics ADAP
- Adverum Biotechnologies ADVM
- AgomAb Therapeutics AGMB
- Alvotech ALVO
- Argenx ARGX
